Literature DB >> 3748663

Development of the immune system in very low birth weight (less than 1500 g) premature infants: concentrations of plasma immunoglobulins and patterns of infections.

M Ballow, K L Cates, J C Rowe, C Goetz, C Desbonnet.   

Abstract

Plasma immunoglobulin concentrations of premature infants of birth weight less than 1500 g were measured longitudinally from birth to 10 months chronological age. Infants were divided into two groups based on gestational age (group I: 25-28 wk; group II: 29-32 wk). In the 1st wk of life, plasma IgG levels correlated with gestational age (r = 0.5, p less than 0.001). At 3 months chronological age, the geometric mean plasma IgG levels were 60 mg/dl in group I and 104 mg/dl in group II infants. Most infants remained hypogammaglobulinemic at 6 months with seven of 11 infants in group I and 13 of 21 infants in group II having plasma IgG levels below 200 mg/dl. In the 1st wk of life, plasma IgM concentrations were 7.6 and 9.1 mg/dl in groups I and II, respectively. They rose to 41.8 and 34.7 by 8 to 10 months of life. Plasma IgA concentrations were comparable for groups I and II in the 1st wk of life (1.2 and 0.6 mg/dl, respectively), but at 1 month of age group I infants had a transient increase in IgA which was not seen in the group II infants (4.5 versus 1.9 mg/dl, respectively, p less than 0.02). This transient elevation in IgA did not correlate with type or route of feeding or amounts of transfused blood. Group I and group II infants had comparable rates of infections prior to discharge from the nursery (p = 0.27). After discharge, the 43 preterm infants followed until 10 months chronological age had a significantly higher incidence of infections than 41 term infants (p = 0.04).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3748663     DOI: 10.1203/00006450-198609000-00019

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  50 in total

Review 1.  Promising stratagems for reducing the burden of neonatal sepsis.

Authors:  N Modi; R Carr
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-09       Impact factor: 5.747

Review 2.  Can polyclonal intravenous immunoglobulin limit cytokine mediated cerebral damage and chronic lung disease in preterm infants?

Authors:  P V Mohan; W Tarnow-Mordi; B Stenson; P Brocklehurst; K Haque; V Cavendish; A Cust
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-01       Impact factor: 5.747

3.  Prolonged exclusive breastfeeding, autumn birth and increased gestational age are associated with lower risk of fever in children with hand, foot, and mouth disease.

Authors:  Q Zhu; Y Li; N Li; Q Han; Z Liu; Z Li; J Qiu; G Zhang; F Li; N Tian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-26       Impact factor: 3.267

Review 4.  Risk factors and prevention of late-onset sepsis in premature infants.

Authors:  L Corbin Downey; P Brian Smith; Daniel K Benjamin
Journal:  Early Hum Dev       Date:  2010-01-29       Impact factor: 2.079

5.  Acute shift in immune response to microbial activators in very-low-birth-weight infants.

Authors:  M B Veber; S Cunningham-Rundles; M Schulman; F Mandel; P A Auld
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

Review 6.  New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

Authors:  L Hammarström; C I Smith
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

Review 7.  Current status of intravenous immunoglobulin in preventing or treating neonatal bacterial infections.

Authors:  L E Weisman; D F Cruess; G W Fischer
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

Review 8.  Toward improving mucosal barrier defenses: rhG-CSF plus IgG antibody.

Authors:  Aryeh Simmonds; Edmund F LaGamma
Journal:  Indian J Pediatr       Date:  2006-11       Impact factor: 1.967

Review 9.  Considerations in the pharmacologic treatment and prevention of neonatal sepsis.

Authors:  Chris Stockmann; Michael G Spigarelli; Sarah C Campbell; Jonathan E Constance; Joshua D Courter; Emily A Thorell; Jared Olson; Catherine M T Sherwin
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

10.  Distribution of the IgG Fc receptor, FcRn, in the human fetal intestine.

Authors:  Uzma Shah; Bonny L Dickinson; Richard S Blumberg; Neil E Simister; Wayne I Lencer; W Allan Walker
Journal:  Pediatr Res       Date:  2003-02       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.